CIK: 0001534261
Total reported value
$1.3B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Loxo Oncology INC | Stock-Other | 10.68% | — | — | |
| 2 | SG7 | Sage Therapeutics INC | Stock-Other | 7.51% | — | — | |
| 3 | ✓ | Foundation Medicine INC | Stock-Other | 7.06% | — | — | |
| 4 | 2655787D | Blueprint Medicines CORP | Stock-Other | 5.15% | — | -6.62% | |
| 5 | EVH | Evolent Health INC - A | Stock-Other | 4.88% | — | — | |
| 6 | AGIO | Agios Pharmaceuticals INC | Stock-Other | 4.85% | — | +7.37% | |
| 7 | SGMOQ | Sangamo Therapeutics INC | Stock-Other | 4.56% | — | +64.71% | |
| 8 | CLVSEUR | Clovis Oncology INC | Stock-Other | 4.50% | — | +465.22% | |
| 9 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 4.28% | — | — | |
| 10 | ONCEEUR | Spark Therapeutics INC | Stock-Other | 3.76% | — | +25.93% | |
| 11 | GILD | Gilead Sciences INC | Stock-Healthcare | 3.53% | — | — | |
| 12 | KRG | Kite Realty Group Trust | Stock-Real Estate | 3.45% | — | +111.76% | |
| 13 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 3.10% | +0.03% | +90.91% | |
| 14 | GNMK | Genmark Diagnostics INC | Stock-Other | 3.00% | — | +71.25% | |
| 15 | EPZMEUR | Epizyme INC | Stock-Other | 2.90% | — | +7.22% | |
| 16 | BOLDEUR | Audentes Therapeutics INC | Stock-Other | 2.83% | — | +53.85% | |
| 17 | ✓ | Stock-Other | 2.53% | — | +154.90% | ||
| 18 | T8S | Tesaro INC | Stock-Other | 2.48% | — | +174.29% | |
| 19 | VYGR | Voyager Therapeutics INC | Stock-Other | 2.45% | — | +48.00% | |
| 20 | CDXS | Codexis INC | Stock-Other | 2.40% | — | +76.30% | |
| 21 | GBTUSD | Global Blood Therapeutics In | Stock-Other | 2.17% | — | +111.82% | |
| 22 | ILMN | Illumina INC | Stock-Healthcare | 2.02% | +0.06% | — | |
| 23 | MYOKEUR | Myokardia INC | Stock-Other | 1.91% | — | +49.06% | |
| 24 | SYRSEUR | Syros Pharmaceuticals INC | Stock-Other | 1.08% | — | — | |
| 25 | CTMX | Cytomx Therapeutics INC | Stock-Other | 1.02% | — | — | |
| 26 | MYGN | Myriad Genetics INC | Stock-Other | 0.96% | — | — | |
| 27 | OVID | Ovid Therapeutics INC | Stock-Other | 0.86% | — | — | |
| 28 | JNCEEUR | Jounce Therapeutics INC | Stock-Other | 0.83% | — | +23.08% | |
| 29 | EDIT | Editas Medicine INC | Stock-Other | 0.83% | — | — | |
| 30 | MDRX | Veradigm INC | Stock-Other | 0.71% | — | -51.61% | |
| 31 | FATE | Fate Therapeutics INC | Stock-Other | 0.66% | — | — | |
| 32 | AMRSEUR | Amyris INC | Stock-Other | 0.59% | — | — | |
| 33 | PACB | Pacific Biosciences Of Calif | Stock-Other | 0.40% | -0.42% | -57.14% | |
| 34 | ✓ | Curis INC | Stock-Other | 0.06% | — | -63.04% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CLVSEUR | Clovis Oncology INC | +3.6% | +465.22% | Add |
| 2 | SGMOQ | Sangamo Therapeutics INC | +2% | +64.71% | Add |
| 3 | ✓ | Loxo Oncology INC | +1.7% | — | Unchanged |
| 4 | KRG | Kite Realty Group Trust | +1.5% | +111.76% | Add |
| 5 | ALNY | Alnylam Pharmaceuticals INC | +1.4% | +90.91% | Add |
| 6 | ✓ | +1.2% | +154.90% | Add | |
| 7 | T8S | Tesaro INC | +0.9% | +174.29% | Add |
| 8 | CDXS | Codexis INC | +0.5% | +76.30% | Add |
| 9 | BOLDEUR | Audentes Therapeutics INC | +0.2% | +53.85% | Add |
| 10 | GNMK | Genmark Diagnostics INC | 0% | +71.25% | Add |
| 11 | GBTUSD | Global Blood Therapeutics In | 0% | +111.82% | Add |
| 12 | MYOKEUR | Myokardia INC | -0.2% | +49.06% | Add |
| 13 | ✓ | Curis INC | -0.3% | -63.04% | Trim |
| 14 | ONCEEUR | Spark Therapeutics INC | -0.5% | +25.93% | Add |
| 15 | SYRSEUR | Syros Pharmaceuticals INC | -0.6% | — | Unchanged |
| 16 | CTMX | Cytomx Therapeutics INC | -0.8% | — | Unchanged |
| 17 | JNCEEUR | Jounce Therapeutics INC | -0.9% | +23.08% | Add |
| 18 | EDIT | Editas Medicine INC | -0.9% | — | Unchanged |
| 19 | VYGR | Voyager Therapeutics INC | -1.5% | +48.00% | Add |
| 20 | MDRX | Veradigm INC | -1.6% | -51.61% | Trim |
| 21 | PACB | Pacific Biosciences Of Calif | -1.7% | -57.14% | Trim |
| 22 | 2655787D | Blueprint Medicines CORP | -1.8% | -6.62% | Trim |
| 23 | EVH | Evolent Health INC - A | -2% | — | Unchanged |
| 24 | EPZMEUR | Epizyme INC | -2% | +7.22% | Add |
| 25 | ✓ | Foundation Medicine INC | -2.1% | — | Unchanged |
| 26 | SG7 | Sage Therapeutics INC | -3.2% | — | Unchanged |
| 27 | AGIO | Agios Pharmaceuticals INC | -3.3% | +7.37% | Add |
| 28 | XBI | Ss Spdr S&p Biotech ETF | — | NEW | New buy |
| 29 | GILD | Gilead Sciences INC | — | NEW | New buy |
| 30 | ILMN | Illumina INC | — | NEW | New buy |
| 31 | ✓ | Amyris INC | — | EXIT | Sold out |
| 32 | MYGN | Myriad Genetics INC | — | NEW | New buy |
| 33 | OVID | Ovid Therapeutics INC | — | NEW | New buy |
| 34 | FATE | Fate Therapeutics INC | — | NEW | New buy |
| 35 | AMRSEUR | Amyris INC | — | NEW | New buy |
| 36 | ADVMCHF | Adverum Biotechnologies INC | — | EXIT | Sold out |